Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant <i>Staphylococcus aureus</i> Infective Endocarditis

<b>Background.</b> Recurrent therapeutic failures reported for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infective endocarditis (IE) with vancomycin may be due to poor bactericidal activity. Alternative antibacterial approaches using bacteriophages may overcome this...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jonathan Save, Yok-Ai Que, José Entenza, Grégory Resch
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-08-01
Colecção:	Viruses
Assuntos:	bacteriophage phage therapy infective endocarditis MRSA vancomycin
Acesso em linha:	https://www.mdpi.com/1999-4915/14/8/1792
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!